Low-grade Nonhodgkin lymphoma (LG-NHL) is characterized by indolent clinical course, which consist of marginal zone lymphoma (MZL), follicular lymphoma (FL), chronic lymphocytic leukemia/small lymphocytic lymphoma, lymphoplasmacytic lymphoma, waldenstrom macroglobulinemia (WM) as the most common ...
CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J Pathol 1995;176:259-267.Ristamaki R, Joensuu H, Soderstrom KO, Jal- kanen S. CD44v6 expression in non-Hodgkin's lympho... R Ristamäki,H Joensuu,KO Söderstöm,... 被引...
The results of autografting in patients with relapsed low grade non-Hodgkin''s Lymphoma (NHL) have generally been disappointing due to the failure to maintain remission and the late development of myelodysplasia. Most series have used regimens that include total body irradiation and purged stem cel...
TO THE EDITOR: Although the quest for improved cure rates of any cancer is paramount, the suggestion by Cabanillas 1 that it is time for a paradigm shift in our approach to the goals of treatment of patients with advanced indolent or low-grade follicular non-Hodgkin lymphoma (ALGFNHL) towar...
Several prospective studies have also examined the association between B-cell Non-Hodgkin Lymphoma (B-cell NHL) and circulating levels of inflammatory markers providing strong evidence of a subtle role of inflammation in B cell NHL development and progression16,17,18,19,20,21,22,23,24,25,26. ...
We describe a patient presenting with systemic lupus erythematosus (SLE) and concomitant low-grade (Ig) non-Hodgkin's lymphoma of the B cell type (B-NHL). Although the association of autoimmune disorder and lymphoma is well conceived, there is only scarce information available as to the ...
Patients with advanced stage or relapsed low-grade non-Hodgkin's lymphoma (NHL) are not curable using conventional approaches and are usually treated with combination chemotherapy regimens of increasing intensity as needed to reduce disease and palliate symptoms.1 Aggressive approaches using high-dose ...
Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma. relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin''s lymphoma (NHL), including patients with rituximab-refractory fol...
Primary non-Hodgkin lymphoma of the sinonasal cavities: correlation of CT evaluation with clinical outcome. (P = .26).Patients with B-cell primary lymphoma of the maxillary sinus tended to have a good prognosis in contrast to those with T-cell lymphomas ... K Nakamura,S Uehara,J Omagari,...
We report here the results of a multicenter phase II trial of CAMPATH-1H in patients with advanced, low-grade non-Hodgkin's lymphoma (NHL) who were previously treated with chemotherapy. PATIENTS AND METHODS: Fifty patients who had relapsed (n=25) after or were resistant (n = 25) to ...